Wells Fargo & Company Adaptimmune Therapeutics PLC Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Wells Fargo & Company holds 63,967 shares of ADAP stock, worth $28,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,967

Previous 66,821 4.27%

Holding current value

$28,785

Previous $63,000 46.03%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$0.54 - $0.95 $1,541 - $2,711	-2,854 Reduced 4.27%	63,967 $34,000
Q3 2024 Nov 13, 2024	BUY	$0.92 - $1.39 $2,897 - $4,377	3,149 Added 4.95%	66,821 $63,000
Q2 2024 Aug 13, 2024	BUY	$0.83 - $1.47 $7,885 - $13,965	9,500 Added 17.54%	63,672 $62,000
Q1 2024 May 10, 2024	SELL	$0.7 - $1.75 $1,403 - $3,508	-2,005 Reduced 3.57%	54,172 $85,000
Q4 2023 Feb 09, 2024	BUY	$0.43 - $0.79 $615 - $1,131	1,432 Added 2.62%	56,177 $44,000
Q3 2023 Nov 13, 2023	SELL	$0.73 - $1.04 $4,009 - $5,711	-5,492 Reduced 9.12%	54,745 $42,000
Q2 2023 Aug 15, 2023	BUY	$0.9 - $1.51 $48,633 - $81,595	54,037 Added 871.56%	60,237 $55,000
Q2 2022 Aug 12, 2022	SELL	$1.33 - $2.28 $2,122 - $3,638	-1,596 Reduced 20.47%	6,200 $10,000
Q1 2022 May 16, 2022	BUY	$1.73 - $4.06 $4,229 - $9,926	2,445 Added 45.69%	7,796 $15,000
Q3 2021 Nov 15, 2021	SELL	$3.44 - $6.37 $35,497 - $65,732	-10,319 Reduced 65.85%	5,351 $27,000
Q2 2021 Aug 16, 2021	BUY	$3.86 - $5.78 $15,436 - $23,114	3,999 Added 34.26%	15,670 $67,000
Q1 2021 May 13, 2021	BUY	$4.9 - $6.83 $22,099 - $30,803	4,510 Added 62.98%	11,671 $61,000
Q4 2020 Feb 09, 2021	BUY	$4.0 - $9.2 $16,640 - $38,272	4,160 Added 138.62%	7,161 $39,000
Q3 2020 Nov 05, 2020	BUY	$7.66 - $10.78 $8,081 - $11,372	1,055 Added 54.21%	3,001 $25,000
Q2 2020 Aug 13, 2020	BUY	$2.58 - $12.1 $4,375 - $20,521	1,696 Added 678.4%	1,946 $20,000
Q1 2020 May 14, 2020	BUY	$1.2 - $4.52 $300 - $1,130	250 New	250 $1,000

Others Institutions Holding ADAP

# of Institutions

Shares Held

123M

Call Options Held

34.2K

Put Options Held

16.3K

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $73.5M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Adaptimmune Therapeutics PLC Transaction History